Back to Journals » Cancer Management and Research

Cancer Management and Research


Journal Articles:

- 331 records -

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals

Wang Z, Xie H, Guo LP, Cai QL, Shang ZQ, Jiang N, Niu YJ

Cancer Management and Research 2017, 9:679-689

Published Date: 21 November 2017

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Lin Z, Lv WZ, Wang SY, Zou JL, Con YY, Wang ZH, Xiao M, Peng PJ

Cancer Management and Research 2017, 9:671-677

Published Date: 20 November 2017

Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials

Li S, Zhou K, Che G, Yang M, Su J, Shen C, Yu P

Cancer Management and Research 2017, 9:657-670

Published Date: 16 November 2017

Expression of minichromosome maintenance genes in renal cell carcinoma

Zhong HB, Chen B, Neves H, Xing JC, Ye YX, Lin Y, Zhuang GH, Zhang SD, Huang JY, Kwok HF

Cancer Management and Research 2017, 9:637-647

Published Date: 15 November 2017

Risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy: a retrospective Chinese population study

Wang Y, Bhandari A, Yang F, Zhang W, Xue L, Liu H, Zhang X, Chen C

Cancer Management and Research 2017, 9:627-635

Published Date: 15 November 2017

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S, Shen Z

Cancer Management and Research 2017, 9:611-626

Published Date: 14 November 2017

Training surgeons in shared decision-making with cancer patients aged 65 years and older: a pilot study

Geessink NH, Schoon Y, Olde Rikkert MGM, van Goor H

Cancer Management and Research 2017, 9:591-600

Published Date: 10 November 2017

Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers

Oh BY, Cho J, Hong HK, Bae JS, Park WY, Joung JG, Cho YB

Cancer Management and Research 2017, 9:581-589

Published Date: 8 November 2017

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells

Kong XQ, Zhang XQ, Huang YX, Tang LR, Peng QQ, Li JL

Cancer Management and Research 2017, 9:573-580

Published Date: 2 November 2017

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Zheng HL, Hong H, Zhang LL, Cai X, Hu M, Cai YP, Zhou B, Lin JY, Zhao CG, Hu WL

Cancer Management and Research 2017, 9:565-572

Published Date: 1 November 2017

Clinical aspects of foot health and their influence on quality of life among breast cancer survivors: a case–control study

Palomo-López P, Rodríguez-Sanz D, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Guerrero-Martín J, Calvo-Lobo C, López-López D

Cancer Management and Research 2017, 9:545-551

Published Date: 1 November 2017

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer

He JQ, Wang XF, Cai JH, Wang W, Qin XY

Cancer Management and Research 2017, 9:539-544

Published Date: 25 October 2017

Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study

Zhu Q, Qiao G, Xu C, Guo D, Tang J, Duan R, Li Y

Cancer Management and Research 2017, 9:525-537

Published Date: 19 October 2017

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging

Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I

Cancer Management and Research 2017, 9:503-511

Published Date: 16 October 2017

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, Qi J, Zhao X

Cancer Management and Research 2017, 9:481-493

Published Date: 9 October 2017

Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study

Tao LY, Yuan CH, Ma ZL, Jiang B, Xiu DR

Cancer Management and Research 2017, 9:471-479

Published Date: 3 October 2017

Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma

Li YJ, Yang X, Zhang WB, Yi C, Wang F, Li P

Cancer Management and Research 2017, 9:443-451

Published Date: 28 September 2017

Challenging the standard of care in advanced melanoma: focus on pembrolizumab

Abdul-Karim RM, Cowey CL

Cancer Management and Research 2017, 9:433-442

Published Date: 25 September 2017

Unintended target effect of anti-BCL-2 DNAi

Ebrahim AS, Kandouz M, Emara N, Sugalski AB, Lipovich L, Al-Katib AM

Cancer Management and Research 2017, 9:427-432

Published Date: 22 September 2017

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K

Cancer Management and Research 2017, 9:397-410

Published Date: 13 September 2017

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

Vasylyev A, Molostvova V, Rebrov BA, Makarova J, Zaritskey A, Ptushkin V, Ramazanova R, Popovych Y, Tsyapka O, Pashanov E

Cancer Management and Research 2017, 9:387-395

Published Date: 7 September 2017

SIRT1 gene polymorphisms and risk of lung cancer

Lv Y, Lin SY, Peng F

Cancer Management and Research 2017, 9:381-386

Published Date: 4 September 2017

Head and neck cancer: improving outcomes with a multidisciplinary approach

Lo Nigro C, Denaro N, Merlotti A, Merlano M

Cancer Management and Research 2017, 9:363-371

Published Date: 18 August 2017

Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?

Sabater S, Andres I, Lopez-Honrubia V, Berenguer R, Sevillano M, Jimenez-Jimenez E, Rovirosa A, Arenas M

Cancer Management and Research 2017, 9:351-362

Published Date: 9 August 2017

Survivorship of patients with head and neck cancer receiving care in a tertiary health facility in Nigeria

Okwor VC, Fagbamigbe AF, Fawole OI

Cancer Management and Research 2017, 9:331-338

Published Date: 21 July 2017

Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women

Lofters AK, Vahabi M, Fardad M, Raza A

Cancer Management and Research 2017, 9:323-329

Published Date: 19 July 2017

The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix

Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, Chen QH

Cancer Management and Research 2017, 9:315-322

Published Date: 18 July 2017

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab

Chen WC, Kanate AS, Craig M, Petros WP, Hazlehurst LA

Cancer Management and Research 2017, 9:307-314

Published Date: 12 July 2017

Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma

Zhang L, Wu H, Yuan W, Zheng J

Cancer Management and Research 2017, 9:279-286

Published Date: 7 July 2017

What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist

Ghanem S, El Bitar S, Hossri S, Weerasinghe C, Atallah JP

Cancer Management and Research 2017, 9:267-278

Published Date: 6 July 2017

Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy

Shao LD, Peng QQ, Du KX, He JY, Dong YP, Lin XY, Li JL, Wu JX

Cancer Management and Research 2017, 9:249-258

Published Date: 29 June 2017

Management of malignant pleural effusion: challenges and solutions

Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I

Cancer Management and Research 2017, 9:229-241

Published Date: 23 June 2017

Chemotherapy-associated paronychia treated with 2% povidone–iodine: a series of cases

Capriotti K, Capriotti J, Pelletier J, Stewart K

Cancer Management and Research 2017, 9:225-228

Published Date: 26 June 2017

Emerging use of everolimus in the treatment of neuroendocrine tumors

Gajate P, Martínez-Sáez O, Alonso-Gordoa T, Grande E

Cancer Management and Research 2017, 9:215-224

Published Date: 20 June 2017

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

Chuzi S, Tavora F, Cruz M, Costa R, Chae YK, Carneiro BA, Giles FJ

Cancer Management and Research 2017, 9:207-213

Published Date: 14 June 2017

Can biosimilars help achieve the goals of US health care reform?

Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G

Cancer Management and Research 2017, 9:197-205

Published Date: 1 June 2017

Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions

Nwabuko OC, Igbigbi EE, Chukwuonye II, Nnoli MA

Cancer Management and Research 2017, 9:189-196

Published Date: 22 May 2017

Considering renal risk while managing cancer

Shahinian VB, Bahl A, Niepel D, Lorusso V

Cancer Management and Research 2017, 9:167-178

Published Date: 16 May 2017

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment

González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, Grothey A

Cancer Management and Research 2017, 9:149-158

Published Date: 27 April 2017

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia

Alakel N, Stölzel F, Mohr B, Kramer M, Oelschlägel U, Röllig C, Bornhäuser M, Ehninger G, Schaich M

Cancer Management and Research 2017, 9:97-102

Published Date: 29 March 2017

New developments in the management of Waldenström macroglobulinemia

Abeykoon JP, Yanamandra U, Kapoor P

Cancer Management and Research 2017, 9:73-83

Published Date: 10 March 2017

Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay

Block TS, Murphy TI, Munster PN, Nguyen DP, Lynch FJ

Cancer Management and Research 2017, 9:65-72

Published Date: 6 March 2017

Update on the optimal use of bortezomib in the treatment of multiple myeloma

Mohan M, Matin A, Davies FE

Cancer Management and Research 2017, 9:51-63

Published Date: 2 March 2017

Feasibility of an exercise intervention for fatigued breast cancer patients at a community-based cardiac rehabilitation program

De Jesus S, Fitzgeorge L, Unsworth K, Massel D, Suskin N, Prapavessis H, Sanatani M

Cancer Management and Research 2017, 9:29-39

Published Date: 10 February 2017

Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study

Danwilai K, Konmun J, Sripanidkulchai B, Subongkot S

Cancer Management and Research 2017, 9:11-18

Published Date: 31 January 2017

Implantation of permanent pleural catheter for palliation of malignant pleural effusion

Meier M, Mortensen MR, Larsen LU

Cancer Management and Research 2016, 8:129-133

Published Date: 8 November 2016

Atypical teratoid/rhabdoid tumors: challenges and search for solutions

Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK

Cancer Management and Research 2016, 8:115-125

Published Date: 16 September 2016

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

Desar IME, Constantinidou A, Kaal SEJ, Jones RL, van der Graaf WTA

Cancer Management and Research 2016, 8:95-104

Published Date: 17 August 2016

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

Gianoukakis AG, Flores NM, Pelletier CL, Forsythe A, Wolfe GR, Taylor MH

Cancer Management and Research 2016, 8:67-76

Published Date: 30 May 2016

Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine

Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP

Cancer Management and Research 2016, 8:57-65

Published Date: 19 May 2016

Multidisciplinary management for esophageal and gastric cancer

Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD

Cancer Management and Research 2016, 8:39-44

Published Date: 22 April 2016

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab

Gollamudi J, Parvani JG, Schiemann WP, Vinayak S

Cancer Management and Research 2016, 8:21-31

Published Date: 18 February 2016

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A

Cancer Management and Research 2016, 8:11-20

Published Date: 4 February 2016

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study

Mouysset JL, Freier B, van den Bosch J, Levaché CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G

Cancer Management and Research 2016, 8:1-10

Published Date: 21 January 2016

Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report

Tang R, Kain T, Herman J, Seery T

Cancer Management and Research 2015, 7:357-360

Published Date: 19 November 2015

Clinical utility of RapidArcTM radiotherapy technology

Infusino E

Cancer Management and Research 2015, 7:345-356

Published Date: 12 November 2015

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma

Aguiar-Bujanda D, Blanco-Sánchez MJ, Hernández-Sosa M, Galván-Ruíz S, Hernández-Sarmiento S

Cancer Management and Research 2015, 7:319-330

Published Date: 27 October 2015

Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study

Lakomy R, Rogowski W, Piko B, Mihaylova Zh, Pritzova E, Kvocekova L

Cancer Management and Research 2015, 7:311-318

Published Date: 23 October 2015

Targeting autophagy in cancer management – strategies and developments

Ozpolat B, Benbrook DM

Cancer Management and Research 2015, 7:291-299

Published Date: 11 September 2015

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

Mandrik O, Corro Ramos I, Knies S, Al M, Severens JL

Cancer Management and Research 2015, 7:279-289

Published Date: 25 August 2015

The treatment landscape in thyroid cancer: a focus on cabozantinib

Weitzman SP, Cabanillas ME

Cancer Management and Research 2015, 7:265-278

Published Date: 19 August 2015

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy

Karakashev SV, Reginato MJ

Cancer Management and Research 2015, 7:253-264

Published Date: 12 August 2015

Potential of epigenetic therapies in the management of solid tumors

Valdespino V, Valdespino PM

Cancer Management and Research 2015, 7:241-251

Published Date: 31 July 2015

Clinical management of grade III oligodendroglioma

Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A

Cancer Management and Research 2015, 7:213-223

Published Date: 27 July 2015

Review of advanced catheter technologies in radiation oncology brachytherapy procedures

Zhou J, Zamdborg L, Sebastian E

Cancer Management and Research 2015, 7:199-211

Published Date: 16 July 2015

Treatment of metastatic colorectal cancer: focus on panitumumab

Tay RY, Wong R, Hawkes EA

Cancer Management and Research 2015, 7:189-198

Published Date: 24 June 2015

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study

Hecht JR, Mitchell EP, Yoshino T, Welslau M, Lin X, Chow Maneval E, Paolini J, Lechuga MJ, Kretzschmar A

Cancer Management and Research 2015, 7:165-173

Published Date: 15 June 2015

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer

Greasley R, Khabazhaitajer M, Rosario DJ

Cancer Management and Research 2015, 7:153-164

Published Date: 12 June 2015

Cancer therapy and cardiovascular risk: focus on bevacizumab

Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N

Cancer Management and Research 2015, 7:133-143

Published Date: 3 June 2015

Expanding role of lenalidomide in hematologic malignancies

Ghosh N, Grunwald MR, Fasan O, Bhutani M

Cancer Management and Research 2015, 7:105-119

Published Date: 2 May 2015

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials

Gabrail N, Yanagihara R, Spaczyński M, Cooper W, O’Boyle E, Smith C, Boccia R

Cancer Management and Research 2015, 7:83-92

Published Date: 17 March 2015

Afatinib for the treatment of metastatic non-small cell lung cancer

Joshi M, Rizvi SM, Belani CP

Cancer Management and Research 2015, 7:75-82

Published Date: 19 February 2015

Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma

Gunnarsson O, Pfanzelter NR, Cohen RB, Keefe SM

Cancer Management and Research 2015, 7:65-73

Published Date: 11 February 2015

Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system

Zullig LL, Williams CD, Fortune-Britt AG

Cancer Management and Research 2015, 7:19-35

Published Date: 14 January 2015

Biliary stenting in advanced malignancy: an analysis of predictive factors for survival

Afshar M, Khanom K, Ma YT, Punia P

Cancer Management and Research 2014, 6:475-479

Published Date: 10 December 2014

Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review

Pacioles T, Seth R, Orellana C, John I, Panuganty V, Dhaliwal R

Cancer Management and Research 2014, 6:467-473

Published Date: 8 December 2014

Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients

Bayoumi Y, Heikal T, Darweish H

Cancer Management and Research 2014, 6:459-465

Published Date: 27 November 2014

Higher susceptibility of NOD/LtSz-scid Il2rg-/- NSG mice to xenotransplanted lung cancer cell lines

Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T

Cancer Management and Research 2014, 6:431-436

Published Date: 21 October 2014

MicroRNA dysregulation as a prognostic biomarker in colorectal cancer

Dong Y, Yu J, Ng SS

Cancer Management and Research 2014, 6:405-422

Published Date: 14 October 2014

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

Poulsen HS, Urup T, Michaelsen SR, Staberg M, Villingshøj M, Lassen U

Cancer Management and Research 2014, 6:373-387

Published Date: 26 September 2014

Interpreting overall survival results when progression-free survival benefits exist in today's oncology landscape: a metastatic renal cell carcinoma case study

Tang Y, Bycott P, Åkerborg Ö, Jönsson L, Negrier S, Chen C

Cancer Management and Research 2014, 6:365-371

Published Date: 22 September 2014

Treating advanced melanoma: current insights and opportunities

Tronnier M, Mitteldorf C

Cancer Management and Research 2014, 6:349-356

Published Date: 10 September 2014

Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?

Asiri MA, Tunio MA, Mohamed R, Bayoumi Y, Alhadab A, Saleh RM, AlArifi MS, Alobaid A

Cancer Management and Research 2014, 6:339-348

Published Date: 9 September 2014

Fertility preservation and GnRHa for chemotherapy: debate

Blumenfeld Z

Cancer Management and Research 2014, 6:313-315

Published Date: 19 August 2014

Computational prognostic indicators for breast cancer

Yang X, Ai X, Cunningham JM

Cancer Management and Research 2014, 6:301-312

Published Date: 12 July 2014

Prognostic stratification of colorectal cancer patients: current perspectives

Schneider NI, Langner C

Cancer Management and Research 2014, 6:291-300

Published Date: 2 July 2014

High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy

Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K

Cancer Management and Research 2014, 6:261-265

Published Date: 4 June 2014

Future of bisphosphonates and denosumab for men with advanced prostate cancer

Iranikhah M, Stricker S, Freeman MK

Cancer Management and Research 2014, 6:217-224

Published Date: 3 May 2014

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives

Díaz-López A, Moreno-Bueno G, Cano A

Cancer Management and Research 2014, 6:205-216

Published Date: 25 April 2014

Genetic factors and breast cancer laterality

Amer MH

Cancer Management and Research 2014, 6:191-203

Published Date: 16 April 2014

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP

Cancer Management and Research 2014, 6:135-147

Published Date: 19 March 2014

Multiple neoplasms, single primaries, and patient survival

Amer MH

Cancer Management and Research 2014, 6:119-134

Published Date: 5 March 2014

Fertility preservation during cancer treatment: clinical guidelines

Rodriguez-Wallberg KA, Oktay K

Cancer Management and Research 2014, 6:105-117

Published Date: 4 March 2014

DNA repair in cancer: emerging targets for personalized therapy

Abbotts R, Thompson N, Madhusudan S

Cancer Management and Research 2014, 6:77-92

Published Date: 19 February 2014

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel

Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B

Cancer Management and Research 2013, 5:401-408

Published Date: 9 December 2013

Personalized treatment for advanced colorectal cancer: KRAS and beyond

Patel GS, Karapetis CS

Cancer Management and Research 2013, 5:387-400

Published Date: 21 November 2013

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S

Cancer Management and Research 2013, 5:377-385

Published Date: 19 November 2013

The claudin family of proteins in human malignancy: a clinical perspective

Ding L, Lu Z, Lu Q, Chen YH

Cancer Management and Research 2013, 5:367-375

Published Date: 8 November 2013

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J

Cancer Management and Research 2013, 5:327-336

Published Date: 3 October 2013

Focal low-dose rate brachytherapy for the treatment of prostate cancer

Tong WY, Cohen G, Yamada Y

Cancer Management and Research 2013, 5:315-325

Published Date: 13 September 2013

Critical appraisal of the potential use of cannabinoids in cancer management

Cridge BJ, Rosengren RJ

Cancer Management and Research 2013, 5:301-313

Published Date: 30 August 2013

Perspectives on the immunologic microenvironment of astrocytomas

Hewedi IH, Radwan NA, Shash LS, Elserry TH

Cancer Management and Research 2013, 5:293-299

Published Date: 30 August 2013

AKT-independent PI3-K signaling in cancer – emerging role for SGK3

Bruhn MA, Pearson RB, Hannan RD, Sheppard KE

Cancer Management and Research 2013, 5:281-292

Published Date: 26 August 2013

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419

Raufi A, Ebrahim AS, Al-Katib A

Cancer Management and Research 2013, 5:225-233

Published Date: 27 August 2013

Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

Merlini L, Cartenì G, Iacobelli S, Stelitano C, Airoldi M, Balcke P, Keil F, Haslbauer F, Belton L, Pujol B

Cancer Management and Research 2013, 5:205-214

Published Date: 2 August 2013

Cancer-associated thrombosis: clinical presentation and survival

Amer MH

Cancer Management and Research 2013, 5:165-178

Published Date: 26 July 2013

The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer

Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Williams CD, Jackson GL

Cancer Management and Research 2013, 5:157-163

Published Date: 24 July 2013

New and emerging combination therapies for esophageal cancer

Wiedmann MW, Mössner J

Cancer Management and Research 2013, 5:133-146

Published Date: 27 June 2013

Serous endometrial intraepithelial carcinoma: a case series and literature review

Pathiraja P, Dhar S, Haldar K

Cancer Management and Research 2013, 5:117-122

Published Date: 17 June 2013

Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery

Sugimoto K, Shimizu N, Oki T, Nose K, Nishioka T, Adomi S, Ohzeki T, Esa A, Uemura H

Cancer Management and Research 2013, 5:85-89

Published Date: 24 May 2013

Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer

Tantraworasin A, Seateang S, Lertprasertsuke N, Arreyakajohn N, Kasemsarn C, Patumanond J

Cancer Management and Research 2013, 5:77-84

Published Date: 6 June 2013

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Shimada M, Itamochi H, Kigawa J

Cancer Management and Research 2013, 5:67-76

Published Date: 8 May 2013

Advanced medullary thyroid cancer: pathophysiology and management

Ferreira CV, Siqueira DR, Ceolin L, Maia AL

Cancer Management and Research 2013, 5:57-66

Published Date: 8 May 2013

Critical appraisal of the use of regorafenib in the management of colorectal cancer

Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, Morgillo F

Cancer Management and Research 2013, 5:49-55

Published Date: 12 April 2013

Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece

Fragoulakis V, Kastritis E, Psaltopoulou T, Maniadakis N

Cancer Management and Research 2013, 5:37-48

Published Date: 10 April 2013

Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

Lopez-Basave HN, Morales-Vasquez F, Ruiz-Molina JM, Namendys-Silva SA, Vela-Sarmiento I, Ruan JM, Padilla Rosciano AE, Calderillo-Ruiz G, Diaz-Romero C, Herrera-Gomez A, Meneses-Garcia AA

Cancer Management and Research 2013, 5:31-36

Published Date: 4 April 2013

Endoscopic endonasal approach for the treatment of a large clival giant cell tumor complicated by an intraoperative internal carotid artery rupture

Iacoangeli M, Di Rienzo A, Re M, Alvaro L, Nocchi N, Gladi M, De Nicola M, Scerrati M

Cancer Management and Research 2013, 5:21-24

Published Date: 30 January 2013

Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

Nojiri S, Kusakabe A, Fujiwara K, Shinkai N, Matsuura K, Iio E, Miyaki T, Nomura T, Sobue S, Sano H, Hasegawa I, Ohno T, Takahashi Y, Orito E, Joh T

Cancer Management and Research 2012, 4:423-429

Published Date: 18 December 2012

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

Chan DL, Morris DL, Rao A, Chua TC

Cancer Management and Research 2012, 4:413-422

Published Date: 23 November 2012

New drugs and combinations for the treatment of soft-tissue sarcoma: a review

Somaiah N, von Mehren M

Cancer Management and Research 2012, 4:397-411

Published Date: 23 November 2012

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells

Thamilselvan V, Menon M, Thamilselvan S

Cancer Management and Research 2012, 4:383-395

Published Date: 9 November 2012

Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS® lexicon standards?

Masroor I, Azeemuddin M, Sakhawat S, Beg M, Sohail S, Ahmed R, Ul-Haq I, Mehboob J

Cancer Management and Research 2012, 4:379-382

Published Date: 7 November 2012

Current treatment options for the management of esophageal cancer

Mawhinney MR, Glasgow RE

Cancer Management and Research 2012, 4:367-377

Published Date: 2 November 2012

Autophagy as a target for cancer therapy: new developments

Carew JS, Kelly KR, Nawrocki ST

Cancer Management and Research 2012, 4:357-365

Published Date: 11 October 2012

Pelvic exenteration for colorectal cancer: oncologic outcome in 59 patients at a single institution

López-Basave HN, Morales-Vásquez F, Herrera-Gómez Á, Padilla Rosciano A, Meneses-Garcíá A, Ruiz-Molina JM

Cancer Management and Research 2012, 4:351-356

Published Date: 11 October 2012

The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study

Agarwal R, Saluja P, Pham A, Ledbetter K, Bains S, Varghese S, Clements J, Kim YH

Cancer Management and Research 2012, 4:347-350

Published Date: 10 October 2012

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

Osorio M, Gracia E, Reigosa E, Hernandez J, de la Torre A, Saurez G, Perez K, Viada C, Cepeda M, Carr A, Ávila Y, Rodríguez M, Fernandez LE

Cancer Management and Research 2012, 4:341-345

Published Date: 5 October 2012

Patient perception of disease control and psychological distress

Mazzotti E, Sebastiani C, Marchetti P

Cancer Management and Research 2012, 4:335-340

Published Date: 27 September 2012

Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival

Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC

Cancer Management and Research 2012, 4:325-334

Published Date: 17 September 2012

Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain

Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC

Cancer Management and Research 2012, 4:309-323

Published Date: 17 September 2012

Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer

Mahasiripanth T, Hokputsa S, Niruthisard S, Bhattarakosol P, Patumraj S

Cancer Management and Research 2012, 4:269-279

Published Date: 23 August 2012

Lenalidomide for the treatment of relapsed and refractory multiple myeloma

van de Donk NW, Görgün G, Groen RW, Jakubikova J, Mitsiades CS, Hideshima T, Laubach J, Nijhof IS, Raymakers RA, Lokhorst HM, Richardson PG, Anderson KC

Cancer Management and Research 2012, 4:253-268

Published Date: 14 August 2012

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Fisher R, Larkin J

Cancer Management and Research 2012, 4:243-252

Published Date: 8 August 2012

Retinoids in the treatment of glioma: a new perspective

Mawson AR

Cancer Management and Research 2012, 4:233-241

Published Date: 7 August 2012

Occupational exposure to wood dust and formaldehyde and risk of nasal, nasopharyngeal, and lung cancer among Finnish men

Siew SS, Kauppinen T, Kyyrönen P, Heikkila P, Pukkala E

Cancer Management and Research 2012, 4:223-232

Published Date: 7 August 2012

The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN

Cancer Management and Research 2012, 4:195-205

Published Date: 26 July 2012

Update on the management of invasive bladder cancer 2012

Goethuys H, Van Poppel H

Cancer Management and Research 2012, 4:177-182

Published Date: 18 July 2012

Nodal involvement pattern in resectable lung cancer according to tumor location

Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y

Cancer Management and Research 2012, 4:151-158

Published Date: 7 June 2012

Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity

Wojcinski S, Nuengsri S, Hillemanns P, Schmidt W, Deryal M, Ertan K, Degenhardt F

Cancer Management and Research 2012, 4:121-127

Published Date: 27 April 2012

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

Aitini E, Rossi A, Morselli P, Vivorio B, Bruschi A, Bottura C, Colombo GL.

Cancer Management and Research 2012, 4:99-103

Published Date: 27 March 2012

Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study

Estevinho F, Soares M, Azevedo I, Queiroga H, Parente B, Brito U, Teixeira E, Sotto-Mayor R, Araújo A

Cancer Management and Research 2012, 4:91-97

Published Date: 13 March 2012

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options

Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C

Cancer Management and Research 2012, 4:75-89

Published Date: 12 March 2012

Psychological and sexual disorders in long-term breast cancer survivors

Pumo V , Milone G, Iacono M, Rametta Giuliano S, Di Mari A, Lopiano C, Bordonaro S, Tralongo P

Cancer Management and Research 2012, 4:61-65

Published Date: 24 February 2012

C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:39-53

Published Date: 24 February 2012

Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:31-38

Published Date: 16 February 2012

Are Toll-like receptor gene polymorphisms associated with prostate cancer?

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:23-29

Published Date: 7 February 2012

Erratum

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:319-320

Published Date: 5 December 2011

Patient–provider communication data: linking process and outcomes in oncology care

Kennedy Sheldon L, Hong F, Berry DL

Cancer Management and Research 2011, 3:311-317

Published Date: 18 November 2011

Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver

Abedini F, Ismail M, Hosseinkhani H, Tengku Ibrahim TA, Omar AR, Chong PP, Hair Bejo M, Domb AJ

Cancer Management and Research 2011, 3:301-309

Published Date: 9 September 2011

Use of capecitabine in management of early colon cancer

Hameed H, Cassidy J

Cancer Management and Research 2011, 3:295-299

Published Date: 19 August 2011

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

Dimitropoulos C, Hillas G, Nikolakopoulou S, Kostara K, Sagris K, Vlastos F, Alchanatis M

Cancer Management and Research 2011, 3:287-294

Published Date: 17 August 2011

Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique

Madhuri TK, Tailor A, Butler-Manuel S

Cancer Management and Research 2011, 3:253-255

Published Date: 6 July 2011

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:247-251

Published Date: 6 July 2011

Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia

Molica S, Mirabelli R, Molica M, Levato L, Mauro F, Foà R

Cancer Management and Research 2011, 3:211-217

Published Date: 1 June 2011

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Wacheck V, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr W, Valent P

Cancer Management and Research 2011, 3:157-175

Published Date: 10 May 2011

Interpreting clinical assays for histone deacetylase inhibitors

Martinet N, Bertrand P

Cancer Management and Research 2011, 3:117-141

Published Date: 9 May 2011

Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis

Coventry BJ, Weightman MJ, Skinner JM, Bradley J

Cancer Management and Research 2011, 3:101-108

Published Date: 18 April 2011

Chemoprevention of prostate cancer with nutrients and supplements

Van Poppel H, Tombal B

Cancer Management and Research 2011, 3:91-100

Published Date: 6 April 2011

Capecitabine in the management of colorectal cancer

Hirsch BR, Zafar SY

Cancer Management and Research 2011, 3:79-89

Published Date: 24 March 2011

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

David L DeRemer, Katerina Katsanevas, Celalettin Ustun

Cancer Management and Research 2011, 3:65-78

Published Date: 10 March 2011

Critical appraisal of trastuzumab in treatment of advanced stomach cancer

Judith Meza-Junco, Heather-Jane Au, Michael B Sawyer

Cancer Management and Research 2011, 3:57-64

Published Date: 3 March 2011

Cardiovascular risk during hormonal treatment in patients with prostate cancer

Hein Van Poppel, Bertrand Tombal

Cancer Management and Research 2011, 3:49-55

Published Date: 2 March 2011

Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes

Katia Maalouf, Elias Baydoun, Sandra Rizk

Cancer Management and Research 2011, 3:39-47

Published Date: 14 February 2011

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Gina M Mantia-Smaldone, Robert P Edwards, Anda M Vlad

Cancer Management and Research 2011, 3:25-38

Published Date: 30 December 2010

Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management

Emanuele Neri, Lorenzo Faggioni, Lorenzo Cini, et al

Cancer Management and Research 2011, 3:17-24

Published Date: 30 December 2010

From antiangiogenesis to hypoxia: current research and future directions

Christopher Rice, L Eric Huang

Cancer Management and Research 2011, 3:9-16

Published Date: 20 December 2010

Reduced cancer risk in vegetarians: an analysis of recent reports

Amy Joy Lanou, Barbara Svenson

Cancer Management and Research 2011, 3:1-8

Published Date: 20 December 2010

Cancer chemotherapy: targeting folic acid synthesis

Nicole Hagner, Markus Joerger

Cancer Management and Research 2010, 2:293-301

Published Date: 19 November 2010

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

Georgios Hillas, Petros Bakakos, Miltiadis Trichas, et al

Cancer Management and Research 2010, 2:287-291

Published Date: 15 November 2010

Review of catumaxomab in the treatment of malignant ascites

Martin Sebastian

Cancer Management and Research 2010, 2:283-286

Published Date: 8 November 2010

The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice

Mette Mogensen, Gregor BE Jemec

Cancer Management and Research 2010, 2:277-282

Published Date: 28 October 2010

FACE: the barefaced facts of AI potency

Alain Monnier

Cancer Management and Research 2010, 2:267-276

Published Date: 27 October 2010

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art

Piotr Milecki, Piotr Martenka, Andrzej Antczak, et al

Cancer Management and Research 2010, 2:243-253

Published Date: 11 October 2010

New developments in treatment of ovarian carcinoma: focus on trabectedin

Philippe A Cassier, Aude Duret, Olivier Trédan, et al

Cancer Management and Research 2010, 2:233-242

Published Date: 1 October 2010

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al

Cancer Management and Research 2010, 2:219-223

Published Date: 17 September 2010

Treatment of cutaneous melanoma: current approaches and future prospects

Alain P Algazi, Christopher W Soon, Adil I Daud

Cancer Management and Research 2010, 2:197-211

Published Date: 17 August 2010

Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer

Daiki Ogawara, Minoru Fukuda, Yoichi Nakamura, et al

Cancer Management and Research 2010, 2:191-195

Published Date: 11 August 2010

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al

Cancer Management and Research 2010, 2:165-168

Published Date: 28 June 2010

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell

Cancer Management and Research 2010, 2:143-156

Published Date: 1 June 2010

Management of metastatic renal cell carcinoma in patients with poor prognosis

Andrea Bullock, David F McDermott, Michael B Atkins

Cancer Management and Research 2010, 2:123-132

Published Date: 24 May 2010

Global cancer research initiative

Richard R Love

Cancer Management and Research 2010, 2:105-109

Published Date: 3 May 2010

Role of bevacizumab therapy in the management of glioblastoma

Scott J Peak, Victor A Levin

Cancer Management and Research 2010, 2:97-104

Published Date: 22 April 2010

Rituximab for the treatment of patients with chronic lymphocytic leukemia

M Gentile, E Vigna, C Mazzone, et al

Cancer Management and Research 2010, 2:71-81

Published Date: 11 March 2010

Everolimus – a new approach in the treatment of renal cell carcinoma

G Anandappa, AE Hollingdale, TG Eisen

Cancer Management and Research 2010, 2:61-70

Published Date: 9 March 2010

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Frederick Lansigan, Diane M Stearns, Francine Foss

Cancer Management and Research 2010, 2:53-59

Published Date: 5 February 2010

Evaluation of degarelix in the management of prostate cancer

Hendrik Van Poppel

Cancer Management and Research 2010, 2:39-52

Published Date: 25 January 2010

Optimal management of cancer anorexia–cachexia syndrome

Josep M Argilés, Mireia Olivan, Sílvia Busquets, et al

Cancer Management and Research 2010, 2:27-38

Published Date: 22 January 2010

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

Catherine Oakman, Marta Pestrin, Elena Zafarana, et al

Cancer Management and Research 2010, 2:13-25

Published Date: 7 January 2010

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma

Ibrahim T Aldoss, Susan M Blumel, Philip J Bierman

Cancer Management and Research 2009, 1:155-165

Published Date: 12 November 2009

Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations

Margarita García, Ana Clopés, Jordi Bruna

Cancer Management and Research 2009, 1:137-150

Published Date: 30 October 2009

The role of azacitidine in the management of myelodysplastic syndromes (MDS)

KS Götze, C Müller-Thomas, C Peschel

Cancer Management and Research 2009, 1:119-130

Published Date: 9 October 2009

Bortezomib in the management of multiple myeloma

Jacob P Laubach, Constantine S Mitsiades, Teru Hideshima, et al

Cancer Management and Research 2009, 1:107-117

Published Date: 8 September 2009

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, et al

Cancer Management and Research 2009, 1:89-97

Published Date: 10 August 2009

Evolving role of cetuximab in the treatment of colorectal cancer

Gunter Schuch, Sebastian Kobold, Carsten Bokemeyer

Cancer Management and Research 2009, 1:79-88

Published Date: 23 July 2009

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

Aminah Jatoi, Shauna L Hillman, Katie L Allen Ziegler, Philip J Stella, et al.

Cancer Management and Research 2009, 1:61-68

Published Date: 17 June 2009

Patient-derived acute myeloid leukemia (AML) bone marrow cells display distinct intracellular kinase phosphorylation patterns

Keith Shults, Leanne Flye, Lisa Green, Thomas Daly, et al.

Cancer Management and Research 2009, 1:49-59

Published Date: 15 May 2009

Validation of the cell cycle G2 delay assay in assessing ionizing radiation sensitivity and breast cancer risk

Jeff W Hill, Kristina Tansavatdi, Kristin L Lockett, Glenn O Allen, et al.

Cancer Management and Research 2009, 1:39-48

Published Date: 30 April 2009

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

Anthony V Nguyen, Micaela Martinez, Michael J Stamos, Mary P Moyer, Kestutis Planutis, Christopher Hope, Randall F Holcombe

Cancer Management and Research 2009, 1:25-37

Published Date: 3 April 2009

TGFβ signaling supports survival and metastasis of endometrial cancer cells

XiuFen Lei, Long Wang, Junhua Yang, Lu-Zhe Sun

Cancer Management and Research 2009, 1:15-24

Published Date: 1 April 2009